Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Neuroscience, 156(3), 693699
This narrative review summarizes the current knowledge on the efficacy and safety of oral vitamin B12 (cobalamin) treatment (replacement) in Biermers disease (pernicious anemia)
This maldigestion produces a more slowly progressive and long-term partial depletion of vitamin B12 stores
Knowing your status allows for targeted treatment using methylfolate and methylcobalamin (active forms of folate and Vitamin B12)
Description SLU-PP-332 Research Grade Peptide Laboratory Use Only SLU-PP supplied by D&L Peptides is a high-purity synthetic peptide provided exclusively for laboratory research purposes
For patients on over 1,000 mg per day, tapering over 2-6 months is usually warranted, with changes between 125-250mg every 2-3 or more weeks
